Novel HADHA Mutation Causes Mitochondrial Protein Deficiency and Neuromuscular Disease

Authors

  • Amit Vatkar Department of Pediatrics, Seth V.C. Gandhi and M.A. Vora Municipal Rajawadi Hospital, Mumbai, Maharashtra, India.
  • S. Joshi Nishigandha Department of Pediatrics, Seth V.C. Gandhi and M.A. Vora Municipal Rajawadi Hospital, Mumbai, Maharashtra, India.
  • Smita Patil Department of Pediatrics, Seth V.C. Gandhi and M.A. Vora Municipal Rajawadi Hospital, Mumbai, Maharashtra, India.
  • Mumtaz Shariff Department of Pediatrics, D.Y. Patil Hospital, Mumbai, Maharashtra, India.

DOI:

https://doi.org/10.9734/bpi/acmmr/v11/7030E

Keywords:

HADHA gene, mutation, mitochondrial trifunctional protein deficiency, fatty acid oxidation disorder, neuromuscular disease, neuropathy, neuromyopathy

Abstract

Mitochondrial trifunctional protein deficiency (MTP deficiency) is a rare genetic disorder affecting oxidation of long-chain fatty acids. It typically causes severe neonatal symptoms like heart/liver disease, hypoglycemia, and metabolic acidosis. It can also gradually present with peripheral neuropathy, episodic rhabdomyolysis, and vision loss. Progressive peripheral neuropathy is an irreversible complication. We report a unique case of a 5-year-old boy with slowly worsening limb weakness. Genetic analysis revealed a novel homozygous HADHA mutation causing his MTP deficiency, representing the first described occurrence in India. Exome sequencing comprehensively analyzed genes. The patient exhibited sensorimotor axonal neuropathy with secondary muscle atrophy, reflecting neuromyopathy. Our study provides further insight into genotype-phenotype correlations in mitochondrial trifunctional protein deficiency.

Published

2023-12-29

How to Cite

Amit Vatkar, S. Joshi Nishigandha, Smita Patil, & Mumtaz Shariff. (2023). Novel HADHA Mutation Causes Mitochondrial Protein Deficiency and Neuromuscular Disease. Advanced Concepts in Medicine and Medical Research Vol. 11, 74–78. https://doi.org/10.9734/bpi/acmmr/v11/7030E